STTCOMP IMU, FA Long.
IMUGENE LTD
SP 0.032
Market Cap $80 mil
Cash $12 mil
biotech ... IMMUNO-ONCOLOGY
IMU cancelled a presentation in Melb this week to go to Vienna instead where they have a strategic partnership with a Viennese medical university. There is steady newsflow due this year for 3 platforms at various stages. Have been some continual large orders bought over the last few weeks, some serious interest. Cashed up after cr late 2017.
Imugene Limited (IMU) is an Australian immuno-oncology focused Biopharmaceutical
Company developing HER2 + ve gastric and breast cancer vaccines. The Group s
lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates
a polyclonal antibody response to HER2/neu.
STTCOMP IMU, FA Long. IMUGENE LTD SP 0.032 Market Cap $80 mil...
Add XAO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8,586.9 |
Change
-23.500(0.27%) |
Mkt cap ! n/a | |||
| Open | High | Low |
| 8,610.4 | 8,644.8 | 8,585.3 |
| XAO (ASX) Chart |